MBX Biosciences, Inc. Common Stock (MBX) — Defensive Interval Ratio
MBX Biosciences, Inc. Common Stock (MBX) has a Defensive Interval Ratio of 9971 days as of March 2026. Defensive assets of $397.92 Million (cash $-, short-term investments $394.76 Million, receivables $3.16 Million) cover 9971 days of daily cash needs of $39.91K/day. Check MBX Biosciences, Inc. Common Stock (MBX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
MBX Biosciences, Inc. Common Stock Defensive Interval Ratio (2022–2025)
This chart shows how MBX Biosciences, Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 9971 days, meaning defensive assets of $397.92 Million can fund 9971 days of operations without new revenue. Also explore MBX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for MBX Biosciences, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for MBX Biosciences, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see MBX Biosciences, Inc. Common Stock market cap and net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 7079 days | $300.54 Million | $42.45K/day | $- | $298.42 Million | ▲ +28 days |
| 2024 | 7051 days | $213.48 Million | $30.28K/day | $- | $212.80 Million | ▲ +2369 days |
| 2023 | 4682 days | $50.36 Million | $10.76K/day | $- | $50.15 Million | ▲ +2725 days |
| 2022 | 1957 days | $18.39 Million | $9.40K/day | $- | $18.25 Million | — |